Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex | Synapse

February 1, 2006

Ver artículo completo

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

DFDavid Neal FranzCincinnati Children's Hospital Medical Center JLJennifer LeonardBaylor College of Medicine CTCynthia TudorCincinnati Children's Hospital Medical Center

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Oral rapamycin therapy can induce regression of astrocytomas associated with TSC and may offer an alternative to operative therapy of these lesions.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Franz et al. (Wed,) studied this question.

synapsesocial.com/papers/69d8fc33f544bba627bed854 https://doi.org/https://doi.org/10.1002/ana.20784

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Hepatocellular Carcinoma: Molecular Pathways and New Therapeutic Targets2005 · 285 citations
2Dual Inhibition of mTOR and Estrogen Receptor Signaling<i>In vitro</i>Induces Cell Death in Models of Breast Cancer2005 · 335 citations
3Pineal region giant cell astrocytoma associated with tuberous sclerosis2005 · 18 citations
4Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF2005 · 127 citations
5Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis2003 · 385 citations